Novavax Inc (NASDAQ:NVAX) is held by 229 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 15,470,365 | 275,802 | 1.82% | $103,960,853.00 |
| SHAH CAPITAL MANAGEMENT | 31 Dec, 2025 | 14,558,780 | 2,747,000 | 23.26% | $97,835,002.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 12,901,549 | 128,496 | 1.01% | $86,698,409.00 |
| State Street Corp | 31 Dec, 2025 | 9,523,646 | 2,326,927 | 32.33% | $63,998,901.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 8,290,665 | 2,088,517 | 33.67% | $55,713,268.00 |
| Sanofi | 31 Dec, 2025 | 6,880,481 | 0 | 0.00% | $46,236,832.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 5,992,798 | 1,718,719 | 40.21% | $40,271,603.00 |
| UBS Group AG | 31 Dec, 2025 | 4,894,284 | 1,378,081 | 39.19% | $32,889,587.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 4,470,083 | 2,342,804 | 110.13% | $30,038,958.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,721,323 | -70,741 | -1.87% | $25,012,096.00 |
| Morgan Stanley | 31 Dec, 2025 | 3,717,984 | 2,641,540 | 245.40% | $24,984,861.00 |
| Allianz Asset Management GmbH | 31 Dec, 2025 | 2,324,142 | 914,408 | 64.86% | $15,618,234.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 2,181,118 | 1,391,842 | 176.34% | $14,657,114.00 |
| Northern Trust Corp | 31 Dec, 2025 | 1,453,976 | -75,141 | -4.91% | $9,770,718.00 |
| TSP Capital Management Group, LLC | 31 Dec, 2025 | 1,389,065 | -10,000 | -0.71% | $9,334,517.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,335,053 | 3,767 | 0.28% | $8,971,556.00 |
| Barclays Plc | 31 Dec, 2025 | 1,102,300 | -663,353 | -37.57% | $7,407,455.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,073,727 | -212,145 | -16.50% | $7,215,446.00 |
| Monaco Asset Management SAM | 31 Dec, 2025 | 1,045,000 | 645,000 | 161.25% | $7,022,400.00 |
| SG Americas Securities, LLC | 31 Dec, 2025 | 976,388 | 57,705 | 6.28% | $6,561.00 |